44 results
8-K
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
therapeutic targets against cancers and other diseases. The resulting soluble, antibody-like cytokine/chemokine decoy receptors derived using the QTY … immunotherapy delivery, as well as broadening the range of therapeutic targets addressable by CAR T-cell therapies.
Item 9.01. Financial Statements
8-K
EX-99.1
c05oznt9
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
PRE 14A
sub88v4ho9y
29 Aug 23
Preliminary proxy
4:55pm
424B3
nfod3sp0yxd1q
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
7rm2yxbg439mc
8 Nov 22
Entry into a Material Definitive Agreement
9:15am
8-K
EX-99.1
t46f3devj
2 May 22
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
6m1h 47ify4e78
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am